Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Loxo Oncology, Inc. (LOXO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | | | | |
| Cost of goods sold | 0.0% | | | | |
| Gross profit | 100.0% | | | | |
| Research and development | 657.5% | | | | |
| General and administrative | 158.0% | | | | |
| Depreciation | 0.6% | | | | |
| EBITA | -715.1% | | | | |
| Amortization of intangibles | 0.4% | | | | |
| EBIT | -715.5% | | | | |
| Pre-tax income | -698.9% | | | | |
| Income taxes | 0.0% | | | | |
| Net income | -698.9% | | | | |
|